Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence

Abstract Knowledge of factors associated with superior outcomes in women treated with urethral bulking agents for stress urinary incontinence (SUI) remains limited. The aim of this study was to examine associations between post‐treatment outcomes in women who had undergone polyacrylamide hydrogel in...

Full description

Bibliographic Details
Main Authors: Venetia Hoe, Henry H. Yao, Karla Gough, Helen E. O'Connell
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:BJUI Compass
Subjects:
Online Access:https://doi.org/10.1002/bco2.218
_version_ 1797852925371875328
author Venetia Hoe
Henry H. Yao
Karla Gough
Helen E. O'Connell
author_facet Venetia Hoe
Henry H. Yao
Karla Gough
Helen E. O'Connell
author_sort Venetia Hoe
collection DOAJ
description Abstract Knowledge of factors associated with superior outcomes in women treated with urethral bulking agents for stress urinary incontinence (SUI) remains limited. The aim of this study was to examine associations between post‐treatment outcomes in women who had undergone polyacrylamide hydrogel injections for SUI, and physiological and self‐reported variables captured during pre‐treatment clinical evaluation. A cross‐sectional study was undertaken in female patients treated for SUI with polyacrylamide hydrogel injections by a single urologist between January 2012 and December 2019. Post‐treatment outcome data were gathered in July 2020 using the Patient Global Impression of Improvement (PGI‐I), Urinary Distress Inventory‐short form (UDI‐6), Incontinence Impact Questionnaire (IIQ7), and International Consultation on Incontinence Questionnaire Short Form (ICIQ SF). All other data were gathered from women's medical records including pre‐treatment patient‐reported outcomes. Associations between post‐treatment outcomes and pre‐treatment physiological and self‐reported variables were investigated using regression models. One hundred seven of the 123 eligible patients completed post‐treatment patient‐reported outcome measures. Mean age was 63.1 years (range 25–93 years), and median time between first injection and follow‐up was 51 months (inter‐quartile range 23.5–70 months). Fifty‐five (51%) women had a successful outcome based on PGI‐I scores. Women with type 3 urethral hypermobility pre‐treatment were more likely to report treatment success (PGI‐I). Poor bladder compliance pre‐treatment was associated with greater urinary distress, frequency and severity (UDI‐6 and ICIQ) post‐treatment. Older age was associated with worse urinary frequency and severity (ICIQ) post‐treatment. Associations between patient‐reported outcomes and time between first injection and follow‐up were trivial and not statistically significant. Severity of pre‐treatment incontinence impact (IIQ‐7) was associated with worse incontinence impact post‐treatment. Type 3 urethral hypermobility was associated with a successful outcome, whereas pre‐treatment incontinence impact, poor bladder compliance and older age were associated with poorer self‐reported outcomes. Long‐term efficacy appears to hold in those who responded to initial treatment.
first_indexed 2024-04-09T19:42:13Z
format Article
id doaj.art-8a917f0f35fd4986a6003639fe039c41
institution Directory Open Access Journal
issn 2688-4526
language English
last_indexed 2024-04-09T19:42:13Z
publishDate 2023-05-01
publisher Wiley
record_format Article
series BJUI Compass
spelling doaj.art-8a917f0f35fd4986a6003639fe039c412023-04-04T05:34:43ZengWileyBJUI Compass2688-45262023-05-014326927610.1002/bco2.218Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinenceVenetia Hoe0Henry H. Yao1Karla Gough2Helen E. O'Connell3Department of Urology Western Health Footscray Victoria AustraliaDepartment of Urology Western Health Footscray Victoria AustraliaDepartment of Health Services Research Peter MacCallum Cancer Centre Melbourne Victoria AustraliaDepartment of Urology Western Health Footscray Victoria AustraliaAbstract Knowledge of factors associated with superior outcomes in women treated with urethral bulking agents for stress urinary incontinence (SUI) remains limited. The aim of this study was to examine associations between post‐treatment outcomes in women who had undergone polyacrylamide hydrogel injections for SUI, and physiological and self‐reported variables captured during pre‐treatment clinical evaluation. A cross‐sectional study was undertaken in female patients treated for SUI with polyacrylamide hydrogel injections by a single urologist between January 2012 and December 2019. Post‐treatment outcome data were gathered in July 2020 using the Patient Global Impression of Improvement (PGI‐I), Urinary Distress Inventory‐short form (UDI‐6), Incontinence Impact Questionnaire (IIQ7), and International Consultation on Incontinence Questionnaire Short Form (ICIQ SF). All other data were gathered from women's medical records including pre‐treatment patient‐reported outcomes. Associations between post‐treatment outcomes and pre‐treatment physiological and self‐reported variables were investigated using regression models. One hundred seven of the 123 eligible patients completed post‐treatment patient‐reported outcome measures. Mean age was 63.1 years (range 25–93 years), and median time between first injection and follow‐up was 51 months (inter‐quartile range 23.5–70 months). Fifty‐five (51%) women had a successful outcome based on PGI‐I scores. Women with type 3 urethral hypermobility pre‐treatment were more likely to report treatment success (PGI‐I). Poor bladder compliance pre‐treatment was associated with greater urinary distress, frequency and severity (UDI‐6 and ICIQ) post‐treatment. Older age was associated with worse urinary frequency and severity (ICIQ) post‐treatment. Associations between patient‐reported outcomes and time between first injection and follow‐up were trivial and not statistically significant. Severity of pre‐treatment incontinence impact (IIQ‐7) was associated with worse incontinence impact post‐treatment. Type 3 urethral hypermobility was associated with a successful outcome, whereas pre‐treatment incontinence impact, poor bladder compliance and older age were associated with poorer self‐reported outcomes. Long‐term efficacy appears to hold in those who responded to initial treatment.https://doi.org/10.1002/bco2.218bladder complianceBulkamid®outcomespolyacrylamide hydrogelstress urinary incontinenceurethral hypermobility
spellingShingle Venetia Hoe
Henry H. Yao
Karla Gough
Helen E. O'Connell
Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
BJUI Compass
bladder compliance
Bulkamid®
outcomes
polyacrylamide hydrogel
stress urinary incontinence
urethral hypermobility
title Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
title_full Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
title_fullStr Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
title_full_unstemmed Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
title_short Factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
title_sort factors associated with polyacrylamide hydrogel outcomes in women with stress urinary incontinence
topic bladder compliance
Bulkamid®
outcomes
polyacrylamide hydrogel
stress urinary incontinence
urethral hypermobility
url https://doi.org/10.1002/bco2.218
work_keys_str_mv AT venetiahoe factorsassociatedwithpolyacrylamidehydrogeloutcomesinwomenwithstressurinaryincontinence
AT henryhyao factorsassociatedwithpolyacrylamidehydrogeloutcomesinwomenwithstressurinaryincontinence
AT karlagough factorsassociatedwithpolyacrylamidehydrogeloutcomesinwomenwithstressurinaryincontinence
AT heleneoconnell factorsassociatedwithpolyacrylamidehydrogeloutcomesinwomenwithstressurinaryincontinence